- Home
- OCUL vs HUN Comparison
OCUL vs HUN Comparison
Compare OCUL & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCUL | HUN |
|---|---|---|
| Founded | 2006 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2014 | 2004 |
Fundamental Metrics
Financial Performance| Metric | OCUL | HUN |
|---|---|---|
| Price | $8.64 | $12.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 11 |
| Target Price | ★ $23.56 | $12.09 |
| AVG Volume (30 Days) | 2.3M | ★ 5.3M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.64% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,990,000.00 | ★ $5,683,000,000.00 |
| Revenue This Year | $7.93 | $3.08 |
| Revenue Next Year | $96.07 | $5.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.48 | N/A |
| 52 Week Low | $6.23 | $7.30 |
| 52 Week High | $16.44 | $16.09 |
Technical Indicators
Market Signals| Indicator | OCUL | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 37.85 | 62.54 |
| Support Level | $8.36 | $13.13 |
| Resistance Level | $9.93 | $13.47 |
| Average True Range (ATR) | 0.52 | 0.51 |
| MACD | -0.20 | 0.34 |
| Stochastic Oscillator | 0.00 | 100.00 |
Price Performance
Historical ComparisonAbout OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.